혈액투석 및 복막투석 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Hemodialysis & Peritoneal Dialysis Market size is expected to reach USD 315.60 Billion in 2034 from USD 141.06 Billion (2025) growing at a CAGR of 9.36% during 2026-2034.

The Global Hemodialysis & Peritoneal Dialysis Market is expanding due to the rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Aging populations, increasing incidence of diabetes and hypertension, and lifestyle-related disorders are major contributors to kidney failure cases. Improved healthcare infrastructure and expanded access to renal replacement therapies are significantly driving market demand.

Technological advancements in dialysis equipment, including portable and home-based systems, are transforming patient care models. Growing preference for home dialysis therapies is reducing hospitalization rates and improving quality of life for patients. Favorable reimbursement policies in developed regions and expanding dialysis centers in emerging economies are supporting market growth. Partnerships between healthcare providers and device manufacturers are enhancing treatment accessibility.

Looking forward, the market is expected to benefit from innovations in wearable dialysis devices and biocompatible membranes. Increasing focus on early diagnosis and preventive nephrology care will influence long-term treatment strategies. Expanding healthcare coverage in developing countries and investments in telehealth-enabled dialysis monitoring will create new opportunities. As kidney disease burden rises globally, dialysis therapies will remain essential in renal care management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Hemodialysis
• Peritoneal Dialysis

By Product

• Device
• Consumables
• Services

By End-use

• Home-Based
• Hospital-Based

COMPANIES PROFILED

• Baxter, B Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co Ltd, Nipro Corp, DaVita, BD, Nikkiso Co Ltd, Cantel Medical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Hemodialysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Peritoneal Dialysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Home-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospital-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Product
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Product
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Product
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Product
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Product
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Baxter
  • 9.2.2 B. Braun SE
  • 9.2.3 Fresenius Medical Care AG
  • 9.2.4 Medtronic
  • 9.2.5 Asahi Kasei Medical Co. Ltd
  • 9.2.6 Nipro Corp
  • 9.2.7 DaVita
  • 9.2.8 BD
  • 9.2.9 Nikkiso Co. Ltd
  • 9.2.10 Cantel Medical